Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Catalyft PL Expandable Interbody System

K-Number: K210425 · 2021-05-24

Decision Date2021-05-24
Product CodeMAX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Catalyft PL Expandable Interbody System is a medical device manufactured by Medtronic Sofamor Danek USA, Inc.. It received FDA 510(k) clearance on 2021-05-24 under approval number K210425. The device is classified under product code MAX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Catalyft PL Expandable Interbody System?

Catalyft PL Expandable Interbody System is a medical device that received FDA 510(k) clearance on 2021-05-24. It is manufactured by Medtronic Sofamor Danek USA, Inc.. The 510(k) number is K210425.

When was Catalyft PL Expandable Interbody System approved by the FDA?

Catalyft PL Expandable Interbody System received FDA 510(k) clearance on 2021-05-24, under approval number K210425.

What company makes Catalyft PL Expandable Interbody System?

Catalyft PL Expandable Interbody System is manufactured by Medtronic Sofamor Danek USA, Inc..

What is the FDA product code for Catalyft PL Expandable Interbody System?

The FDA product code for Catalyft PL Expandable Interbody System is MAX.

Related Clinical Trials

Other Devices by Medtronic Sofamor Danek USA, Inc.

View all 76 devices →

Related Devices (Code: MAX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.